Key facts
- This page summarizes Michael G. Grey's Form 4 filing for Horizon Therapeutics Public Ltd Co.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 28 Sep 2023, 16:39.
Michael G. Grey - 28 Sep 2023 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 28 Sep 2023
- Net transaction value
- +$319,200
- SEC form
- 4
- Accepted by SEC
- 28 Sep 2023, 16:39:24 UTC
- Prior SEC filing
- 14 Sep 2023
- Next SEC filing
- 06 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Meghanne Downes, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael G. Grey filed Form 4 for Horizon Therapeutics Public Ltd Co on 28 Sep 2023.
Change
- Previous filing in this sequence was filed on 14 Sep 2023.
- Current net transaction value: +$319,200.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HZNP
transaction
Ordinary Shares
Options Exercise
- Transaction value
- $319,200
- Shares
- +20,000
- Change %
- +103%
- Price
- $15.96*
- Shares after
- 39,361
- Date
- 28 Sep 2023
- Ownership
- Direct
HZNP
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 48,031
- Date
- 28 Sep 2023
- Ownership
- By Davy Trust
HZNP
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,000
- Date
- 28 Sep 2023
- Ownership
- By Family Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HZNP
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 Sep 2023
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 20,000
- Exercise price
- $15.96
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option is fully vested.